Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

NeuroPhage to use $17mm Series D round to bring NPT088 into the clinic; adds $10mm

Executive Summary

New investors joined returning backers Shire PLC and Merieux Developpement for a $17mm Series D financing for NeuroPhage Pharmaceuticals Inc. (fusion proteins for neurodegenerative disorders caused by amyloid-beta, tau, and other types of misfolded proteins).
Deal Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register